FDA Inspection 1161841 — Aaron P. Rapoport, M.D.
The FDA completed an inspection of Aaron P. Rapoport, M.D. on Jan 25, 2022 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 25, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Baltimore, MD (United States)